D. White

发表

Pharmacokinetics of vincristine sulfate in adult cancer patients.

C. Spurr, H. Muss, M. Cooper, 1981, Cancer research.

Chemotherapy versus chemoimmunotherapy in advanced adenocarcinoma of the colon and rectum. A prospective randomized study

C. Spurr, H. Muss, F. Richards, 1979, Cancer.

High- versus standard-dose megestrol acetate in women with advanced breast cancer: a phase III trial of the Piedmont Oncology Association.

C. Spurr, L. Case, H. Muss, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Swallowing Dysfunction is a Common Sequelae After Chemoradiation for Oropharynx Carcinoma

R. D'Agostino, J. Browne, K. Greven, 2008, American journal of clinical oncology.

Advanced epidermoid lung cancer. Prolonged survival after chemotherapy

C. Spurr, H. Muss, M. Cooper, 1980, Cancer.

Combination chemotherapy of advanced non‐oat cell carcinoma of the lung

C. Spurr, H. Muss, M. Cooper, 1979, Cancer.

Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer – a phase II study

W. Blackstock, A. W. Blackstock, D. White, 2002, BMC Cancer.

Treatment of poor risk acute leukemia with sequential high-dose ARA-C and asparaginase.

C. Spurr, H. Muss, M. Cooper, 1984, Blood.

Chemotherapy vs. chemoimmunotherapy with methanol extraction residue of bacillus calmette‐guerin (MER) in advanced breast cancer: A randomized trial by the piedmont oncology association

C. Spurr, H. Muss, M. Cooper, 1981, Cancer.

Adriamycin versus methotrexate in five‐drug combination chemotherapy for advanced breast cancer. A randomized trial

C. Spurr, H. Muss, M. Cooper, 1978, Cancer.

Single agent vincristine by infusion in refractory multiple myeloma.

C. Spurr, L. Case, H. Muss, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Interrupted versus continuous chemotherapy in patients with metastatic breast cancer. The Piedmont Oncology Association.

C. Spurr, L. Case, H. Muss, 1991, The New England journal of medicine.

VP-16-213 in combination chemotherapy with chest irradiation for small-cell lung cancer: a randomized trial of the Piedmont Oncology Association.

H. Muss, P. Zekan, F. Richards, 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Improved tolerance of vincristine by glutamic acid

C. Spurr, L. Case, H. Muss, 2004, Journal of Neuro-Oncology.

Amelioration of vincristine neurotoxicity by glutamic acid.

J. Atkins, H. Muss, P. Zekan, 1988, The American journal of medicine.

Bone marrow evaluation in small cell lung cancer

C. Spurr, H. Muss, M. Cooper, 1984, American journal of clinical oncology.

Adriamycin-methotrexate combination chemotherapy of advanced carcinoma of the cervix.

C. Spurr, H. Muss, M. Cooper, 1977, Obstetrics and Gynecology.

Lack of potentiation of vincristine‐induced neurotoxicity by VP‐16–213

C. Spurr, H. Muss, M. Cooper, 1983, American journal of clinical oncology.

Combination chemotherapy (5-fluorouracil, methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the Piedmont Oncology Association.

C. Spurr, L. Case, H. Muss, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Vinblastine infusion in non-Hodgkin's lymphomas: lack of total cross-resistance with vincristine.

C. Spurr, H. Muss, P. Zekan, 1987, Cancer investigation.

Combination chemotherapy with and without the methanol‐extracted residue of bacillus calmette‐guerin (MER) in extensive non‐small‐cell lung cancer: A prospective randomized study for the piedmont oncology association

C. Spurr, H. Muss, M. Cooper, 1981, Cancer.

Methyl‐ccnu, alone and in combination with vincristine, or vincristine and methotrexate, in advanced bronchogenic carcinoma

C. Spurr, H. Muss, M. Cooper, 1976, Cancer.

CCNU in combination chemotherapy for advanced histologically unfavorable non-Hodgkin's lymphoma

C. Spurr, L. Case, H. Muss, 2004, Cancer Chemotherapy and Pharmacology.

Combination chemotherapy‐radiotherapy with and without the methanol‐extraction residue of bacillus calmette‐guerin (MER) in small cell carcinoma of the lung a prospective randomized trial of the piedmont oncology association

C. Spurr, H. Muss, M. Cooper, 1982, Cancer.

A Phase I‐II Study of Recombinant Intrapleural Alpha Interferon in Malignant Pleural Effusions

H. Muss, Robert Barrett, M. Cooper, 1992, American journal of clinical oncology.

Sequential high-dose ara-C and asparaginase in the therapy of previously treated and untreated patients with acute leukemia.

C. Spurr, H. Muss, P. Zekan, 1985, Seminars in oncology.

Adriamycin and CCNU in the treatment of advanced breast cancer.

C. Spurr, H. Muss, M. Cooper, 1976, Cancer treatment reports.

J. White, H. Muss, B. Powell, 2009, Scandinavian journal of haematology. Supplementum.

Clinical trial of pyridoxine to reduce vincristine neurotoxicity

C. Spurr, J. Atkins, H. Muss, 2005, Journal of Neuro-Oncology.

Clinical trial of folinic acid to reduce vincristine neurotoxicity

L. Case, P. Zekan, M. Cooper, 2004, Cancer Chemotherapy and Pharmacology.

A prospective study of histocompatible leukocyte and platelet transfusions during induction chemotherapy of adult acute nonlymphocytic leukemia.

C. Spurr, H. Muss, M. Cooper, 1981, Medical and pediatric oncology.

Serum alkaline phosphatase determination. Value in the staging of advanced breast cancer.

H. Muss, D. White, V. Howard, 1979, JAMA.

Brain scanning in patients with recurrent breast cancer

H. Muss, D. White, R. Cowan, 1976, Cancer.

Nonseminomatous germ cell cancer of the testis. Reducing treatment‐related morbidity in patients with disseminated disease

C. Spurr, H. Muss, M. Cooper, 1982 .

Cyclophosphamide versus cyclophosphamide, methotrexate, and 5‐fluorouracil in advanced prostatic cancer: A randomized trial

M. Resnick, C. Spurr, H. Muss, 1981, Cancer.

A phase II trial of high‐dose cytarabine and cisplatin in previously untreated non‐small cell carcinoma of the lung. A piedmont oncology association study

C. Spurr, J. Atkins, H. Muss, 1990, Cancer.

A Phase 11 Trial of High-Dose Cytarabine and Cisplatin in Previously Untreated Non-Small Cell Carcinoma of the Lung

C. Spurr, J. Atkins, H. Muss, 1990 .

Histiocytic medullary reticulosis with parallel increases in serum acid phosphatase and disease activity

J. George, D. Sears, D. White, 1976, Cancer.

Prophylactic cranial irradiation in small cell carcinoma of the lung: A Randomized Study

C. Spurr, H. Muss, M. Cooper, 1977 .

Phase I study of twice-weekly gemcitabine and concurrent thoracic radiation for patients with locally advanced non-small-cell lung cancer.

G. Lesser, L. Case, S. Russo, 2001, International journal of radiation oncology, biology, physics.

Twice-weekly gemcitabine and concurrent thoracic radiation for advanced non small-cell lung cancer.

G. Lesser, A. W. Blackstock, F. Richards, 1999, Clinical lung cancer.

Phase I study of vincristine and escalating doses of etoposide

C. Spurr, H. Muss, P. Zekan, 1989, Investigational New Drugs.

Combination high-dose etoposide and vincristine infusion

H. Muss, A. Chauvenet, J. Cruz, 2004, Investigational New Drugs.

Phase II trial of adjuvant radiation and intraperitoneal 5-fluorouracil for locally advanced colon cancer: results with 10-year follow-up.

K. Lohman, L. Case, A. W. Blackstock, 2000, International journal of radiation oncology, biology, physics.

Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: results from INT 0101 (E5188).

S. Martino, C. Osborne, N. Davidson, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Antiemetic therapy in patients treated with high-dose cytosine arabinoside.

B. Powell, R. Capizzi, D. White, 1987, Oncology.

A randomized comparative trial of chemotherapy and irradiation therapy for stage ii breast cancer

C. Spurr, H. Muss, M. Cooper, 1981, Cancer.

A randomized trial of adjuvant chemotherapy and immunotherapy in Stage I and Stage II cutaneous melanoma. An interim report.

C. Spurr, L. Case, H. Muss, 1985, Cancer.

A randomized trial of adjuvant chemotherapy and immunotherapy in stage I and stage II cutaneous melanoma. An interim report

C. Spurr, L. Case, H. Muss, 1985 .

Chemoimmunotherapy for disseminated malignant melanoma: a prospective randomized study.

C. Spurr, H. Muss, M. Cooper, 1978, Cancer treatment reports.

Combination cisplatin and carboplatin in advanced squamous cell carcinoma of the head and neck.

H. Muss, G. Russell, B. Powell, 1996, Cancer Investigation.

Radiographic Complete Response on Post Treatment CT Imaging Eliminates the Need for Adjuvant Neck Dissection After Treatment for Node Positive Head and Neck Cancer

R. D'Agostino, J. Browne, K. Greven, 2008, American journal of clinical oncology.

Vincristine infusion with CHOP-CCNU in diffuse large-cell lymphoma.

C. Spurr, H. Muss, B. Powell, 1990, Cancer investigation.

Treatment of advanced non‐Hodgkin's lymphoma with vincristine infusion

C. Spurr, H. Muss, M. Cooper, 1984, Cancer.

Pharmacokinetics of vincristine infusion.

C. Spurr, H. Muss, M. Cooper, 1981, Cancer treatment reports.

Phase II trial of high-dose cytarabine and cisplatin in locoregional previously untreated squamous carcinoma of the head and neck: a Piedmont Oncology Association Study.

J. Atkins, B. Powell, F. Richards, 1987, Cancer treatment reports.

Phase I study of high-dose cytosine arabinoside and etoposide in patients with advanced malignancies

C. Spurr, J. Atkins, H. Muss, 1987, Cancer Chemotherapy and Pharmacology.

Mitoxantrone and high-dose ara-C in refractory malignancies: a phase I trial.

H. Muss, P. Zekan, B. Powell, 1989, Medical and pediatric oncology.

Therapy of advanced colorectal carcinoma with 5‐fluorouracil and cyclophosphamide in combination with either CCNU or methotrexate

C. Spurr, H. Muss, M. Cooper, 1980, Cancer.

Vincristine by continuous infusion in refractory breast cancer: a phase II study.

H. Muss, M. Cooper, H. Wells, 1983, American journal of clinical oncology.

High‐dose cyclophosphamide and 5‐fluorouracil versus vincristine, doxorubicin, and cyclophosphamide in advanced carcinoma of the breast: A phase III study of the piedmont oncology association (POA)

C. Spurr, L. Case, H. Muss, 1984, Cancer.

Vincristine, doxorubicin, and cyclophosphamide versus low‐dose intravenous cyclophosphamide, methotrexate, and 5‐fluorouracil in advanced breast cancer. A randomized trial of the piedmont oncology association

C. Spurr, H. Muss, M. Cooper, 1982, Cancer.

Combination chemotherapy in advanced breast cancer.: a randomized trial comparing a three-vs a five-drug program.

C. Spurr, H. Muss, M. Cooper, 1977, Archives of internal medicine.

CCNU, bleomycin, and methylprednisolone with or without adriamycin in renal cel carcinoma: a randomized trial.

C. Spurr, H. Muss, M. Cooper, 1977, Cancer treatment reports.

Split-course versus continuous thoracic radiation therapy for limited-stage small-cell lung cancer: final report of a randomized phase III trial.

J. Lovato, T. McCoy, J. Atkins, 2005, Clinical lung cancer.

Phase II study of pyrazine diazohydroxide (NSC 361456) for advanced non small-cell lung cancer.

G. Lesser, L. Case, F. Richards, 2000, Clinical lung cancer.

A randomized trial of chemotherapy (L-PAM vs CMF) and irradiation for node positive breast cancer

C. Spurr, J. Brockschmidt, H. Muss, 1991, Breast Cancer Research and Treatment.

Low-dose ara-C therapy for acute myelogenous leukemia in elderly patients.

T. Morgan, H. Muss, B. Powell, 1989, Leukemia.

Written informed consent in patients with breast cancer

C. Spurr, H. Muss, M. Cooper, 1979, Cancer.

A phase II trial of peg-L-asparaginase in the treatment of non-hodgkins lymphoma

C. Spurr, H. Muss, P. Zekan, 1990, Investigational New Drugs.

Actinomycin D in the treatment of advanced breast cancer

C. Spurr, H. Muss, M. Cooper, 2004, Cancer Chemotherapy and Pharmacology.

Informed consent: Patient information forms in chemotherapy trials

C. Spurr, H. Muss, M. Cooper, 1984, American journal of clinical oncology.

Nonseminomatous germ‐cell cancer of the testis. Reducing treatment‐related morbidity in patients with disseminated disease

C. Spurr, H. Muss, D. Jackson, 1982, Cancer.

Vinblastine and 6-thioguanine in the treatment of advanced breast cancer.

C. Spurr, H. Muss, F. Richards, 1978, Cancer treatment reports.

GR 38032F (GR-C507/75): a novel compound effective in the prevention of acute cisplatin-induced emesis.

D. Gandara, J. Chubb, P. Hesketh, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Nonseminomatous germ cell cancer of the testis. Reducing treatment‐related morbidity in patients with disseminated disease

C. Spurr, H. Muss, M. Cooper, 1982, Cancer.

Brain Scanning in Patients with Advanced Lung Cancer

H. Muss, D. White, R. J. Cowan, 1976 .

Vincristine, doxorubicin and mitomycin (VAM) in patients with advanced breast cancer previously treated with cyclophosphamide, methotrexate and fluorouracil (CMF)

C. Spurr, H. Muss, M. Cooper, 2004, Cancer Chemotherapy and Pharmacology.